Innovations for Healthcare and Wellbeing : Digital Technologies, Ecosystems and Entrepreneurship

• Autore: Schlyakhto Evgeny
• Pubblicazione: Cham : , : Springer, , 2024; ©2024
• Edizione: 1st ed.
• Descrizione fisica: 1 online resource (567 pages)
• Altri autori: IlinIgor DevezasTessaleno Correia LeitãoJoão Carlos CubicoSerena
• Nota di contenuto: Intro -- Preface -- Contents -- Part I: Digital Technologies for Healthcare -- Chapter 1: Information as the Most Important Tool for the Development of Personalized Medicine -- 1.1 Introduction -- 1.2 The Concept of "Big Data" -- 1.3 Digital Health Care -- 1.4 Existing Problems of Big Data Analytics in Medicine -- 1.5 Areas of Successful Use of Big Data and Artificial Intelligence Technologies in the Near Future -- 1.6 Data-Driven Management (DDM) -- 1.7 Conclusions -- References -- Chapter 2: Personalized Approach to Treatment of Malignant Tumors During Pregnancy -- 2.1 Introduction -- 2.2 Gynecological Tumors and Pregnancy -- 2.2.1 Cervical Cancer and Pregnancy -- 2.2.2 Preinvasive Cervical Cancer (High-Grade Squamous Intraepithelial Lesions (HSILs)) in Pregnant Women -- 2.3 Invasive Cervical Cancer During Pregnancy: Diagnostics -- 2.4 Invasive Cervical Cancer During Pregnancy: Treatment -- 2.4.1 Microinvasive Cervical Cancer During Pregnancy -- 2.4.2 Invasive Cervical Cancer During Pregnancy -- 2.5 Fertility After Cervical Cancer Treatment -- 2.6 Ovarian Tumors and Pregnancy -- 2.6.1 Diagnosis of Ovarian Tumors During Pregnancy -- 2.6.2 Therapeutic Tactics for Benign Ovarian Formations During Pregnancy -- 2.6.3 Therapeutic Tactics for Malignant Ovarian Tumors During Pregnancy -- 2.6.4 Fertility After Treatment of Malignant Ovarian Tumors -- 2.6.5 Vulvar Cancer -- 2.6.6 Endometrial Cancer -- 2.7 Breast Cancer and Pregnancy -- 2.7.1 Diagnosis of Breast Cancer During Pregnancy -- 2.7.2 Treatment of Breast Cancer Associated with Pregnancy -- 2.7.3 Surgical Treatment -- 2.7.4 Radiotherapy -- 2.8 Conclusions -- References -- Chapter 3: The Role of Telemedicine Technologies in the Prognosis of Patients with End-Stage Chronic Heart Failure and Heart Transplant Recipients -- 3.1 Introduction. ; 3.2 Implementation of Telerehabilitation and Technological Innovations in Heart Transplant Recipients -- 3.3 Conclusions -- References -- Chapter 4: The Opportunities of Robot-Assisted Surgery in Team Approach in Patients with Severe Comorbidities -- 4.1 Introduction -- 4.2 Advantages and Disadvantages of Robotic Surgery -- 4.3 Anesthesia for Robot-Assisted Operations -- 4.3.1 Narcosis -- 4.3.2 Positioning the Patient on the Operating Table -- 4.3.3 Carboxyperitoneum -- 4.4 Comorbidity/Frailty -- 4.5 Robot-Assisted Operations -- 4.5.1 Pelvic Surgery -- 4.5.1.1 Robot-Assisted Radical Prostatectomy -- 4.5.1.2 Robot-Assisted Adenomectomy -- 4.5.1.3 Robot-Assisted Radical Cystectomy/Cystoprostatectomy (RARC) -- 4.5.1.4 Prostate Surgery in Frail Patients -- 4.5.2 Kidney Surgery -- 4.5.2.1 Partial Nephrectomy -- 4.5.2.2 Radical Nephrectomy -- 4.5.2.3 Robot-Assisted Pyeloplasty (RAP) -- 4.5.2.4 Robotic Kidney Surgery in Comorbid Patients -- 4.5.3 Robot-Assisted Gynecological Surgery -- 4.5.3.1 Robot-Assisted Gynecological Procedures in Comorbid Patients -- 4.5.4 Robot-Assisted General Surgery -- 4.5.4.1 Robotic General Surgery in Comorbid Patients -- 4.5.5 Experiences at the Almazov National Medical Research Center -- 4.6 Conclusions -- References -- Chapter 5: The First Clinical Application of a Therapy Device for Nitric Oxide Synthesis from Atmospheric Air -- 5.1 Introduction -- 5.2 Materials and Methods -- 5.3 Results -- 5.3.1 Patients -- 5.3.2 The Effect of NO Inhalation on Hemodynamics -- 5.3.3 The Effect of NO Inhalation on Gas Exchange and Oxygen Delivery -- 5.3.4 Clinical Course of the Postoperative Period in the Study Groups -- 5.3.5 Side Effects of Inhaled Nitric Oxide Therapy Identified in the Study Groups -- 5.4 Discussion -- 5.5 Conclusions -- References -- Part II: Healthcare Environment and Ecosystems. ; Chapter 6: Mechanism for Development of Medical Hubs as a Basic Element of National Security in Health Care -- 6.1 Introduction -- 6.2 Cluster Approach to the Development of Health Care as a Prerequisite for the Formation of a Medical Hub -- 6.3 Conceptual Model of Regional Competitiveness of a Medical Hub -- 6.4 Medical Hubs as an Innovative Business Development Environment: Goals, Principles, Functions, and Structural Elements -- 6.5 Structure of a Medical Hub Business Model -- 6.6 Life Cycle of a Medical Hub -- 6.7 Strategies of Medical Hub Development and Tools for Their Implementation -- 6.8 Development of Public-Private Partnerships -- 6.9 Marketing Strategy -- 6.10 Production Strategy -- 6.11 Strategy for Scientific and Technological Development and Staff Training -- 6.12 Financial Strategy -- 6.13 Socioeconomic Problems of Creating Medical Hubs in the Regions of Russia -- References -- Chapter 7: Using Enterprise Architecture Approach to Model Healthcare Innovation Hubs -- 7.1 Introduction -- 7.2 Digital Innovation Hubs (DIHs) -- 7.3 Overview of Leading Medical Hubs -- 7.3.1 Health Innovation Hub (HIH), Germany -- 7.3.2 Pfizer Healthcare Hub, Berlin, Freiburg, Germany -- 7.3.3 Health Innovation Hub Ireland (HIHI), Ireland -- 7.3.4 Digital Innovation Hub for Home Hospitalisation, Scotland -- 7.3.5 Genolier Innovation Hub, Switzerland -- 7.3.6 Kantonsspital Baden (KSB) Health Innovation Hub, Switzerland -- 7.3.7 Health Innovation Hub at the University Hospital Zurich, Switzerland -- 7.4 Overview of Medical Hub Structures in Russia -- 7.4.1 The International Medical Cluster (IMC), Skolkovo, Moscow -- 7.4.2 Moscow Center for Innovative Technologies in Healthcare, Moscow -- 7.4.3 Scientific and Educational Medical Cluster "Translational Medicine," St. Petersburg -- 7.5 Business Architecture of Healthcare Innovation Hub -- 7.5.1 Hub Stakeholders. ; 7.5.2 Hub Business Services -- 7.6 The Digital Platform of a Healthcare Innovation Hub -- 7.7 Data of Healthcare Innovation Hubs -- 7.8 Hub Infrastructure -- 7.9 Conclusions -- References -- Chapter 8: Innovation Medical Hub: Data Donation -- 8.1 Introduction -- 8.2 Materials and Methods -- 8.2.1 Identification of the Practical Need for Data Access -- 8.2.2 Literature Search and Analysis -- 8.2.3 Shaping the Requirements for a Data Donation System in Health Care -- 8.2.4 Modeling the Business, IT, and Technology Architecture of a Medical Innovation Hub Data Donation System -- 8.2.5 Verification of the Resulting Models -- 8.3 A Literature Review -- 8.3.1 Specification of the Research Questions -- 8.3.2 Specification of Inclusion and Exclusion Criteria -- 8.3.3 Analysis of Selected Articles -- 8.3.4 Incentives and Value of Data Donation -- 8.4 Results -- 8.5 Discussion -- 8.6 Conclusions -- References -- Chapter 9: Use of the Data-Driven Concept in the Management of a Healthcare Facility -- 9.1 Introduction -- 9.2 The Essence of a Data-Driven Approach -- 9.3 Cases of Implementation of the Data-Driven Concept in Management Regardless of the Field of Activity -- 9.3.1 Sibur Holding -- 9.3.2 SberBank -- 9.4 Case of Implementation of the Data-Driven Concept in the Medical Field -- 9.4.1 The Seoul National University Bundang Hospital -- 9.4.2 The Memorial Sloan Kettering Cancer Center -- 9.4.3 Experience of Using the Data-Driven Concept in Medicine of the Russian Federation -- 9.5 Comparison of Two Business Models of Medical Facility -- 9.6 Difficulties with the Regulatory Framework in Digital Medicine -- 9.7 Results -- 9.8 Conclusions -- References -- Chapter 10: Planning and Management of Vaccine Distribution: Social Vulnerability Index to Reduce Vulnerability in Public Health -- 10.1 Introduction -- 10.2 Materials and Methods -- 10.3 Literature Review. ; 10.3.1 Vaccine Lifecycle Management -- 10.3.1.1 The Case of Kazakhstan -- 10.3.1.2 The EU Practice and Further Cases -- 10.3.1.3 Ecosystem in Vaccine Lifecycle Management -- 10.3.2 Innovative Solutions with IT Support in Vaccine Supply Chain -- 10.3.3 Comparative Literature Review Summary -- 10.4 Results -- 10.4.1 The Inclusion of the Social Vulnerability Index in the Proposed Innovative Model -- 10.5 Discussion -- 10.6 Conclusions -- References -- Part III: Smart Hospital Concept Development within Innovative Healthcare Ecosystems and National Health Systems -- Chapter 11: Medical Organization Architecture in View of Healthcare Digitalization -- 11.1 Introduction -- 11.2 The Current State of Digitalization of Healthcare -- 11.3 Bottleneck Analysis of Digital Health Transformation Processes -- 11.4 An Architectural Approach to the Digitalization of Healthcare -- 11.4.1 Approach to Developing an Architectural Model -- 11.4.2 Motivational Extension -- 11.4.3 Architectural Model Description -- 11.5 Potential Implementation Projects and Results -- 11.6 Conclusion -- References -- Chapter 12: Implementing Data-Driven Management: A Case of the National Heart Center -- 12.1 Introduction -- 12.2 Description of the Research Object -- 12.3 Project Structure -- 12.4 Implementing Process Management and Increasing the Level of Process Maturity -- 12.5 Quality Control and Internal Benchmarking as a Tool for Implementing DDM -- 12.6 Conclusion -- References -- Chapter 13: Using Wearable Devices to Improve the Patients' Quality of Life -- 13.1 Introduction -- 13.2 Literature Review -- 13.3 Wearable Technologies as a Part of the Internet of Things -- 13.3.1 Architecture of the Medical Internet of Things -- 13.3.2 Perception Level: Data Collection -- 13.3.3 Network Layer: Data Transmission and Storage -- 13.3.4 Application Level: Data Interpretation. ; 13.4 The Use of Wearable Devices in Different Spheres of Life.
• Titolo autorizzato: Innovations for Healthcare and Wellbeing
• ISBN: 3-031-53614-2
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910861095203321
• Lo trovi qui: Univ. Federico II
• Serie: Contributions to Management Science Series